Form 1-A/A - Offering Statement [Regulation A]: [Amend]
SEC Accession No. 0001104659-25-005949
Filing Date
2025-01-24
Accepted
2025-01-24 15:27:43
Documents
12

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 1-A/A  
1 primary_doc.xml 1-A/A 18494
2 PART II AND III tm2427963d2_partiiandiii.htm PART II AND III 1664066
3 EXHIBIT 4.1 tm2427963d2_ex4-1.htm EX1A-4 SUBS AGMT 82345
4 EXHIBIT 11.1 tm2427963d2_ex11-1.htm EX1A-11 CONSENT 2173
5 EXHIBIT 12.1 tm2427963d2_ex12-1.htm EX1A-12 OPN CNSL 5699
6 EXHIBIT 13.1 tm2427963d2_ex13-1.htm EX1A-13 TST WTRS 4397
7 GRAPHIC tm2427963d2_partiiandiiiimg1.jpg GRAPHIC 21998
8 GRAPHIC tm2427963d2_partiiandiiiimg2.jpg GRAPHIC 36278
9 GRAPHIC tm2427963d2_partiiandiiiimg3.jpg GRAPHIC 10019
10 GRAPHIC tm2427963d2_ex12-1img01.jpg GRAPHIC 15974
11 GRAPHIC tm2427963d2_ex13-1img01.jpg GRAPHIC 195479
12 GRAPHIC tm2427963d2_ex13-1img02.jpg GRAPHIC 29765
  Complete submission text file 0001104659-25-005949.txt   2205616
Mailing Address 658 W. INDIANTOWN ROAD SUITE 214 JUPTER FL 33458
Business Address 658 W INDIANTOWN RD SUITE 214 JUPITER FL 33458-7535 (561) 575-4451
Cytonics Corp (Filer) CIK: 0001421744 (see all company filings)

EIN.: 208883869 | State of Incorp.: FL
Type: 1-A/A | Act: 33 | File No.: 024-12533 | Film No.: 25553843
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)